YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
YD Bio Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$6.12+0.20 (+3.38%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
YD Bio has not reported a dividend
No dividend per share appears in YD Bio's annual filings since fiscal 2022.